comparemela.com

Latest Breaking News On - Serious adverse events - Page 3 : comparemela.com

BenevolentAI : Inside Information / Ad Hoc Information BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers -March 25, 2024 at 02:05 am EDT

BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers London, UK, 25 March.

United-kingdom
London
City-of
New-york
United-states
Ben-atwell-simon-conway
Joerg-moeller
Fleur-wood
Anne-phelan
Astrazeneca
Company-euronext-amsterdam
Euronext-amsterdam

Pliant Therapeutics Announces Positive Safety And Exploratory Efficacy Data From The INTEGRIS-PSC Phase 2A Trial Of Bexotegrast 320 Mg In Patients Wit...

Pliant Therapeutics Announces Positive Safety And Exploratory Efficacy Data From The INTEGRIS-PSC Phase 2A Trial Of Bexotegrast 320 Mg In Patients Wit...
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states
Toronto
Ontario
Canada
Clin-gastroenterol-hepatol
Terry-horner
Christopher-keenan
Krisv-kowdley
Gideon-hirshfield
Pliant-therapeutics-inc
European-medicines-agency
Drug-administration

LifeSprout Enters into Licensing Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina™ Dermal Filler in Greater China

/PRNewswire/ LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced it.

Hong-kong
Taiwan
Macau
United-states
Boyang
Guangdong
China
Johns-hopkins
Lu-handong
Restylane-defyne
Sashank-reddy
European-union

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.